Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

医学 内科学
作者
Luke Joseph Laffin,Branko Kopjar,Carrie Melgaard,Kathy Wolski,Jessica Ibbitson,Shivani Bhikam,Matthew R. Weir,Elizabeth Ofili,Reena Mehra,James Matthew Luther,Debbie L. Cohen,Ashish Sarraju,Michael J. Wilkinson,John M. Flack,David Rodman,Steven E. Nissen
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:392 (18): 1813-1823 被引量:122
标识
DOI:10.1056/nejmoa2501440
摘要

BACKGROUND: Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. METHODS: In this multicenter, double-blind, randomized, placebo-controlled trial, we assigned participants who were receiving two to five antihypertensive medications and had a blood-pressure measurement of 140/90 mm Hg or higher obtained during an office visit to undergo a standardized antihypertensive regimen for 3 weeks. Subsequently, participants with an average 24-hour ambulatory blood pressure of 130/80 mm Hg or higher were assigned to receive placebo, lorundrostat at a stable dose of 50 mg daily (the stable-dose group), or lorundrostat at a starting dose of 50 mg daily, with an increase to 100 mg daily if systolic blood pressure was 130 mm Hg or higher after 4 weeks (the dose-adjustment group). The primary end point was the change in 24-hour average systolic blood pressure from baseline to week 12, assessed as the least-squares mean difference from placebo (the placebo-adjusted change) in each lorundrostat group. A key secondary end point was the change in 24-hour average systolic blood pressure from baseline to week 4, assessed as the placebo-adjusted change in the combined lorundrostat groups. RESULTS: A total of 285 participants underwent randomization; 94 were assigned to the stable-dose group, 96 to the dose-adjustment group, and 95 to the placebo group. The mean age was 60 years, and 150 participants (53%) were Black. After 12 weeks, the least-squares mean change in 24-hour average systolic blood pressure was -15.4 mm Hg in the stable-dose group, -13.9 mm Hg in the dose-adjustment group, and -7.4 mm Hg in the placebo group. The placebo-adjusted change in blood pressure was -7.9 mm Hg (97.5% confidence interval [CI], -13.3 to -2.6) in the stable-dose group and -6.5 mm Hg (97.5% CI, -11.8 to -1.2) in the dose-adjustment group. The placebo-adjusted change in 24-hour average systolic blood pressure from baseline to week 4 in the combined lorundrostat groups was -5.3 mm Hg (95% CI, -8.4 to -2.3). A potassium level above 6.0 mmol per liter occurred in 5 participants (5%) in the stable-dose group, 7 participants (7%) in the dose-adjustment group, and no participants in the placebo group. CONCLUSIONS: Lorundrostat was associated with greater reductions in 24-hour average blood pressure than placebo in participants with uncontrolled and treatment-resistant hypertension. (Funded by Mineralys Therapeutics; Advance-HTN ClinicalTrials.gov number, NCT05769608.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英俊的铭的应助被STEAM采纳,获得10
1秒前
1秒前
材料牛马发布了新的文献求助10
1秒前
2秒前
lanlandetian发布了新的文献求助30
2秒前
SU完成签到,获得积分10
2秒前
MW完成签到,获得积分10
3秒前
呆萌的莲完成签到,获得积分10
3秒前
Bai_shao完成签到,获得积分10
4秒前
Bay发布了新的文献求助10
4秒前
沈英明完成签到,获得积分10
4秒前
Maverick发布了新的文献求助10
4秒前
顶顶小明完成签到,获得积分10
4秒前
fu发布了新的文献求助10
4秒前
脑洞疼的应助被lxn采纳,获得10
5秒前
吹走霉运发布了新的文献求助30
5秒前
大力的凡旋完成签到,获得积分10
5秒前
Liliz完成签到 ,获得积分10
5秒前
molihuakai的应助被踏实平萱采纳,获得10
6秒前
6秒前
6秒前
newwen完成签到,获得积分10
7秒前
cc发布了新的文献求助10
7秒前
Agoni完成签到,获得积分10
7秒前
Au完成签到 ,获得积分10
8秒前
乐乐的应助被材料牛马采纳,获得10
8秒前
LH完成签到,获得积分10
8秒前
合适的修洁完成签到,获得积分10
9秒前
yier发布了新的文献求助10
9秒前
Jasper的应助被QQ采纳,获得10
9秒前
window1000发布了新的文献求助10
10秒前
Abathur完成签到,获得积分10
10秒前
yang完成签到,获得积分10
10秒前
霍双帅发布了新的文献求助10
11秒前
11秒前
11秒前
11秒前
11秒前
科研通AI6.4的应助被神勇化蛹采纳,获得10
11秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570485
关于积分的说明 21812623
捐赠科研通 7776592
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557522
邀请新用户注册赠送积分活动 2479162